DR-18 Trademark

Pharmaceutical products for the treatment of cancer; Anti-cancer preparations; Tumor suppressing agents; Pharmaceutical products for treatment of cancer by means of activation of the immune system; Pharmaceutical products for treatment of cancer by means of cell therapy; Biological preparations for use in oncology; Engineered cytokine proteins sold as a component ingredient of therapeutic pharmaceuticals for the treatment of cancer; Nucleic acids encoding engineered cytokine proteins sold as a component ingredient of therapeutic pharmaceuticals for the treatment of cancer; Cells genetically engineered to produce engineered cytokine proteins sold as a component ingredient of therapeutic pharmaceuticals for the treatment of cancer

Biological and chemical preparations for use in scientific and medical research; Biological and chemical preparations for use in the manufacture of pharmaceuticals; Biological and chemical preparations for use in the development of immunotherapies, cell therapies, and oncology treatments; Protein in raw material form for scientific and medical research; Engineered proteins for medical and scientific research; Engineered nucleic acids for medical and scientific research; Genetically-engineered cells for medical and scientific research; Therapeutic proteins, nucleic acids, and cells for use in the manufacture of pharmaceutical preparations